Bharat Biotech: News
31 Oct 2024
Andhra PradeshTV5 owner BR Naidu appointed Tirumala Tirupati Devasthanams board chairman
The Andhra Pradesh government has announced the new 24-member governing board for the Tirumala Tirupati Devasthanams (TTD).
23 Jun 2024
COVAXINBharat Biotech includes ICMR as co-owner of COVAXIN patent
Bharat Biotech International (BBIL), a Hyderabad-based biotech company, has added the Indian Council of Medical Research (ICMR) as a co-owner to the patent for their COVID-19 vaccine, COVAXIN.
26 Jan 2023
COVID-19India's 1st nasal COVID-19 vaccine by Bharat Biotech launched
Union Health Minister Dr. Mansukh Mandaviya and Science and Technology Minister Jitendra Singh on Thursday launched Bharat Biotech's iNCOVACC, which is reportedly India's first intranasal COVID-19 vaccine.
27 Dec 2022
COVID-19Bharat Biotech's iNCOVACC: Here's how much COVID-19 nasal vaccine costs
Hyderabad-based vaccine maker Bharat Biotech on Tuesday announced the price of its recently-approved intranasal COVID-19 vaccine, named iNCOVACC.
23 Dec 2022
COVID-19COVID-19 nasal vaccines are available but should you get one?
The Centre has given its nod to Bharat Biotech's nasal vaccine: iNCOVACC. It has been included in the COVID-19 vaccination program and has been approved to be used as a heterologous booster from today.
23 Dec 2022
VaccineCOVID-19: Centre approves Bharat Biotech's nasal vaccine as booster dose
Union Health Minister Mansukh Mandaviya informed on Friday that the Centre has approved Bharat Biotech's nasal vaccine to be used as a heterologous booster.
07 Sep 2022
COVID-19Can nasal spray vaccines stop the spread of COVID-19?
Bharat Biotech's nasal spray vaccine for immunization against COVID-19 has been approved by the Central Drugs Standard Control Organisation (CDSCO).
06 Sep 2022
Mansukh MandaviyaBharat Biotech's nasal COVID-19 vaccine receives drug regulator's nod
The nasal vaccine for immunization against COVID-19, developed by Hyderabad-based vaccine maker Bharat Biotech, has received the approval of the Central Drugs Standard Control Organisation (CDSCO).
15 Aug 2022
United KingdomBharat Biotech completes third-phase of intranasal COVID-19 vaccine trials
The manufacturing body of the made-in-India Covaxin is only steps away from releasing its intranasal vaccine for the virus.
19 Jun 2022
World Health OrganizationClinical trials for nasal COVID-19 vaccine complete: Bharat Biotech
The phase 3 clinical trials of Bharat Biotech's COVID-19 nasal vaccine have been completed, according to Dr. Krishna Ella, the company's Chairman and Managing Director.
29 Apr 2022
World Health OrganizationCentre denies asking Bharat Biotech to address WHO's COVAXIN suspension
The Ministry of External Affairs (MEA) on Friday denied reports that it had asked Bharat Biotech to address issues to avoid the cancellation of the World Health Organization's (WHO) emergency approval for its COVAXIN.
22 Apr 2022
Drugs Controller General of IndiaCOVAXIN likely to get approval for children above 2yrs: Report
Bharat Biotech's COVID-19 vaccine, COVAXIN, is likely to get the Drugs Controller General of India's (DCGI) nod for use among children aged two to 12 years.
03 Jan 2022
COVID-19COVAXIN supply to be increased as teens get COVID-19 vaccines
Pharmaceutical firm Bharat Biotech on Monday said it plans to increase the supply of its COVID-19 vaccine COVAXIN to up to eight crore doses a month, starting February.
01 Dec 2021
Zydus CadilaAre Indian vaccines effective against Omicron? Here's what manufacturers say
The COVID-19 vaccine manufacturers in India are reportedly waiting for "more data" on the new coronavirus variant, Omicron, to assess the efficacy of their vaccines.
03 Nov 2021
World Health OrganizationCOVAXIN gets WHO approval for emergency use listing
The World Health Organization (WHO) on Wednesday granted Emergency Use Listing (EUL) to COVAXIN.
01 Nov 2021
IndiaAustralia accepts COVAXIN as 'recognized' vaccine for incoming travelers
Australia on Monday accepted India's indigenous vaccine, COVAXIN, as a "recognized" vaccine for the purpose of travel to the country.
19 Oct 2021
IndiaCannot cut corners, thorough evaluation needed for COVAXIN EUL: WHO
The World Health Organization (WHO) Monday clarified the reason behind the delay in COVAXIN's emergency use listing (EUL), stating that it is expecting more information from Bharat Biotech on its COVID-19 vaccine.
12 Oct 2021
Health & WellnessCOVAXIN recommended by expert panel for children aged 2-18 years
The Subject Expert Committee (SEC) on COVID-19 has recommended the approval of Bharat Biotech's COVAXIN for children aged between two and 18 years.
03 Oct 2021
World Health OrganizationCOVAXIN trial data for children aged 2-18 submitted to DCGI
Bharat Biotech has reportedly submitted trial data of its COVID-19 vaccine, COVAXIN, for children aged under 18 years to the Drugs and Comptroller General of India (DCGI).
30 Sep 2021
World Health OrganizationDecision on EUL of COVAXIN in October, says WHO
A decision on Bharat Biotech's submission seeking emergency use listing (EUL) for its COVID-19 vaccine COVAXIN will be made in October, the World Health Organization has said.
21 Sep 2021
COVID-19COVAXIN for children: Bharat Biotech completes Phase 2/3 trials
Bharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine, COVAXIN for use in children under 18 years of age and is expected to submit the data by next week to the DCGI, Chairman, and Managing Director of Bharat Biotech International Ltd., Krishna Ella said.
17 Sep 2021
World Health OrganizationBharat Biotech awaits feedback from WHO for COVAXIN's EUL
Bharat Biotech on Friday said it has submitted all the data pertaining to its COVID-19 vaccine COVAXIN to the World Health Organization for EUL and is awaiting feedback from the global health watchdog.
28 Aug 2021
Indian Council of Medical Research (ICMR)Single COVAXIN dose might be enough for those previously infected
A single dose of Bharat Biotech's COVAXIN in previously COVID-19-infected individuals elicits a similar antibody response as obtained with two doses of the vaccine in those without a previous history of the disease, according to an ICMR study.
24 Jul 2021
BrazilBharat Biotech ends its Brazil agreement. What went wrong?
Bharat Biotech on Friday announced the termination its agreement with two foreign firms for the supply of COVAXIN to Brazil.
23 Jul 2021
CoronavirusBharat Biotech commits to supply 500mn COVAXIN doses to Centre
Bharat Biotech on Friday said it has committed to supply over 500 million doses of COVAXIN to the Centre under the countrywide immunization program.
28 May 2021
COVID-19 VaccineBharat Biotech enters contract manufacturing deal for COVAXIN drug substance
Hester Biosciences on Thursday said a memorandum of understanding (MoU) has been signed between Hyderabad-based vaccine maker Bharat Biotech and Gujarat COVID-19 Vaccine Consortium (GCVC) for contract manufacturing the drug substance for COVAXIN.
03 Jul 2021
COVID-19COVAXIN overall 77.8% effective in Phase-3 trial, says Bharat Biotech
COVAXIN, the coronavirus vaccine developed by India's Bharat Biotech, is overall 77.8 percent effective, the company said in a statement today, sharing the final analysis of its phase three trial data.
30 Jun 2021
VaccineBharat Biotech denies wrongdoing in $324mn COVAXIN deal with Brazil
Hyderabad-based pharmaceutical company Bharat Biotech denied any wrongdoing on its part after Brazil suspended a $324 million contract for doses of its COVID-19 vaccine COVAXIN.
22 Jun 2021
VaccineCOVAXIN 77.8% effective; government panel reviews Phase III trial data
COVAXIN, the COVID-19 vaccine developed by Bharat Biotech, has been found 77.8% effective against the viral disease, Phase III trial data reportedly revealed.
16 Jun 2021
VaccineCalf serum absent in COVAXIN, involved in development, government clarifies
COVAXIN, the indigenous COVID-19 vaccine produced by Bharat Biotech, does not contain calf serum, the Union Health Ministry clarified on Wednesday.
07 Jun 2021
All India Institute Of Medical Sciences (AIIMS)AIIMS-Delhi begins screening children for COVAXIN clinical trials from today
The All India Institute of Medical Sciences (AIIMS), Delhi will begin screening children from Monday to conduct clinical trials of the indigenously developed, Bharat Biotech's vaccine against COVID-19, COVAXIN.
29 May 2021
Ministry of Health and Family WelfareHealth Ministry thrashes reports about 'missing' COVAXIN doses
The Health Ministry has slammed news about unaccounted COVAXIN doses as "unfound media reports" adding that these reports are incorrect and not supported by full information on the matter.
28 May 2021
Aam Aadmi Party (AAP)Centre creating 'artificial scarcity' of COVID-19 vaccines: AAP
The AAP on Friday alleged that the Centre is creating artificial scarcity of COVID-19 vaccines to benefit Bharat Biotech and Serum Institute of India, a charge termed by the Delhi BJP as unfounded.
25 May 2021
World Health OrganizationNeed more information to give EUL to COVAXIN: WHO
The World Health Organization (WHO) has said that more information is required from Bharat Biotech, which is seeking emergency use listing (EUL) for its COVID-19 vaccine COVAXIN.
24 May 2021
World Health OrganizationCOVAXIN trials on children are expected to begin in June
Bharat Biotech, the pharmaceutical firm behind India's first indigenous COVID-19 vaccine COVAXIN, may begin trials on children in June and is expecting to receive the license in the third quarter of this year.
21 May 2021
IndiaBharat Biotech to increase COVAXIN production by 200 million doses
Hyderabad-based firm Bharat Biotech has said it will scale up the manufacturing capacity of its coronavirus vaccine, COVAXIN, by an additional 200 million (20 crore) doses per year.
13 May 2021
COVAXINCOVAXIN approved for Phase 2/3 trials on 2-18-year-olds
India's apex drug regulator has granted permission for conducting the Phase II/III clinical trial of Bharat Biotech's COVAXIN in the age group of 2 to 18 years, the Union Health Ministry said on Thursday. The trial will be conducted on 525 healthy volunteers.
12 May 2021
BulandshahrGovernment-owned BIBCOL to produce 2 crore COVAXIN doses every month
To accelerate the production of COVAXIN—the indigenous COVID-19 vaccine developed by Hyderabad-based Bharat Biotech—amid severe vaccine shortage in India, the Centre on Wednesday reportedly gave its nod for production of COVAXIN at government-owned Bharat Immunologicals & Biologicals Corporation Limited (BIBCOL) in Uttar Pradesh's Bulandshahr.
12 May 2021
VaccineCOVAXIN phase 2/3 trials for 2-18-year-olds recommended by expert panel
In a bid to extend the country's vaccination drive to include people below 18 years, an expert panel on Tuesday recommended Hyderabad-based Bharat Biotech's COVID-19 vaccine COVAXIN for phase 2/3 clinical trials on children and adolescents aged two to 18 years.
01 May 2021
Madhya PradeshTruck laden with COVAXIN abandoned for 12 hours, driver missing
A truck carrying 2.40 lakh doses of COVAXIN worth Rs. 8 crore was left parked for nearly 12 hours after its driver went missing under mysterious circumstances in Madhya Pradesh's Narsinghpur district.
29 Apr 2021
VaccineBharat Biotech reduces COVAXIN price to Rs. 400 for states
Hyderabad-based pharmaceutical company Bharat Biotech on Thursday reduced the price of its COVID-19 vaccine, COVAXIN, for state governments.
20 Apr 2021
COVID-19Bharat Biotech to produce 700 million COVAXIN doses per year
To support vaccination campaigns in India and across the globe, Bharat Biotech has ramped up the manufacturing capacity of its COVID-19 vaccine, COVAXIN, to 700 million doses per annum, the vaccine maker said on Tuesday.
31 Mar 2021
BrazilCOVAXIN manufacturing facility fails to meet CGMP standards: Brazilian regulator
The Brazilian health regulator Anvisa denied permission to import Bharat Biotech's COVID-19 vaccine COVAXIN into the country after its authorities found that the plant in which the vaccine is being made did not meet the Current Good Manufacturing Practice requirements.
20 Mar 2021
NepalNepal gives emergency use approval to Bharat Biotech's COVAXIN
Nepal's national drug regulatory authority on Saturday granted emergency use approval to Bharat Biotech's COVAXIN, becoming the third country to approve India's indigenously developed COVID-19 vaccine.
09 Mar 2021
COVAXINCOVAXIN Phase-II trial interim data shows better reactogenicity, safety: Lancet
COVAXIN, the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech, has shown better reactogenicity and safety, Phase II trial interim data published in The Lancet journal showed.
04 Mar 2021
Delhi High CourtDelhi HC pulls up Centre for exporting COVID-19 vaccines
The Delhi High Court on Thursday pulled up the central government over restricted COVID-19 vaccinations in India, even as vaccine exports to other nations continue.
03 Mar 2021
VaccineCOVAXIN 81% effective, offers protection against UK variant: Bharat Biotech
COVAXIN, the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech, has been found to have 81% interim efficacy against preventing infections, the company said on Wednesday.
27 Jan 2021
CoronavirusCOVAXIN may neutralize UK strain of COVID-19: Review report
COVAXIN, developed by Bharat Biotech, has the ability to neutralize the UK variant of the coronavirus, according to a pre-print review by bioRxiv, a free online archive and distribution service for unpublished pre-prints in the life sciences.
24 Jan 2021
VaccineCoronavirus: Nearly 16 lakh vaccinated in India as pace accelerates
As the first phase of COVID-19 vaccinations is underway in India, nearly 16 lakh healthcare and frontline workers have been inoculated, government data showed.
Panel recommends permission for Phase I Intranasal COVID-19 vaccine trial
An expert panel, Central Drugs Standard Control Organisation, (CDSCO) on Tuesday recommended granting permission for conducting the Phase I clinical trial of an intranasal vaccine against COVID-19 developed by Bharat Biotech, official sources said.
19 Jan 2021
CoronavirusCentre issues a new Letter of Comfort to Bharat Biotech
Bharat Biotech secured a fresh Letter of Comfort from the Centre for 45 lakh doses of its COVID-19 vaccine, COVAXIN.
19 Jan 2021
VaccineWho shouldn't take COVAXIN? Maker Bharat Biotech issues fact-sheet
Two days after India started its coronavirus vaccination program, Hyderabad-based Bharat Biotech released guidelines revealing who should receive shots of COVAXIN.
17 Jan 2021
Madhya PradeshCo-WIN app suffers glitches on 1st day of vaccination drive
The COVID-19 Vaccine Intelligence Network (Co-WIN) platform suffered several glitches on the first day of India's vaccination drive.
17 Jan 2021
MaharashtraMeet India's frontline workers who received first COVID-19 vaccine shots
On Saturday, India launched its COVID-19 vaccination drive, inoculating 1.91 lakh people on the first day alone.
13 Jan 2021
CoronavirusCOVAXIN shipped to eleven cities in India: Bharat Biotech
Bharat Biotech, on Wednesday, said that it has successfully air-shipped its COVID-19 vaccine COVAXIN to eleven cities in India in the early hours. It has also donated 16.5 lakh doses to the Centre.
11 Jan 2021
Narendra ModiCentre will sponsor vaccination of healthcare, frontline workers: PM Modi
In his first interaction with chief ministers of all states after India approved two vaccines, Prime Minister Narendra Modi said the federal government will sponsor the vaccination of three crore healthcare and frontline workers.
09 Jan 2021
Madhya PradeshDays after participating in vaccine trial, man dies in Bhopal
A 42-year-old volunteer named Deepak Marawi, from Bhopal in Madhya Pradesh died nearly ten days after he participated in the clinical trial for COVAXIN held at a private hospital, its vice-chancellor said on Saturday.
08 Jan 2021
Oxford UniversitySevere side-effects after COVID-19 vaccine: What are your legal options?
India is looking forward to launching a massive COVID-19 vaccination drive with two vaccines that have been granted emergency use authorization (EUA).
